PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics

被引:15
|
作者
Stevens, Tyler [1 ]
Sangkuhl, Katrin [3 ]
Brown, Jacob T. [2 ]
Altman, Russ B. [3 ,4 ,5 ,6 ]
Klein, Teri E. [3 ,6 ]
机构
[1] Univ Minnesota, Coll Pharm, Duluth, MN 55812 USA
[2] Univ Minnesota, Dept Pharm Practice & Pharmaceut Sci, Duluth, MN 55812 USA
[3] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Biomed Engn, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Genet & Med, Stanford, CA 94305 USA
[6] Stanford Univ, Dept Med, Stanford, CA 94305 USA
来源
PHARMACOGENETICS AND GENOMICS | 2019年 / 29卷 / 06期
关键词
carboxylesterase; 1; methylphenidate; SLC6A2; SLC6A3; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; NO SIGNIFICANT ASSOCIATION; VESICULAR MONOAMINE TRANSPORTER-2; CONDITIONED PLACE PREFERENCE; DL-THREO-METHYLPHENIDATE; O-METHYLTRANSFERASE COMT; INDUCED DOPAMINE RELEASE; INDUCED GENE-EXPRESSION; NEUROTROPHIC FACTOR;
D O I
10.1097/FPC.0000000000000376
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:136 / 154
页数:19
相关论文
共 50 条
  • [1] PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics
    Mitra-Ghosh, Taraswi
    Callisto, Samuel P.
    Lamba, Jatinder K.
    Remmel, Rory P.
    Birnbaum, Angela K.
    Barbarino, Julia M.
    Klein, Teri E.
    Altman, Russ B.
    [J]. PHARMACOGENETICS AND GENOMICS, 2020, 30 (04): : 81 - 90
  • [2] PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics
    Alvarellos, Maria L.
    McDonagh, Ellen M.
    Patel, Sephalie
    McLeod, Howard L.
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2015, 25 (12): : 622 - 630
  • [3] PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics
    Alvarellos, Maria
    Guillemette, Chantal
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2018, 28 (05): : 127 - 137
  • [4] PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics
    Fohner, Alison E.
    McDonagh, Ellen M.
    Clancy, John P.
    Carrillo, Michelle Whirl
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (01): : 39 - 42
  • [5] PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics
    Fohner, Alison E.
    Sparreboom, Alex
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (04): : 164 - 167
  • [6] PharmGKB summary: diuretics pathway, pharmacodynamics
    Thorn, Caroline F.
    Ellison, David H.
    Turner, Stephen T.
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2013, 23 (08): : 449 - 453
  • [7] PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics
    Lowenberg, Daniella
    Thorn, Caroline F.
    Desta, Zeruesenay
    Flockhart, David A.
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2014, 24 (02): : 133 - 138
  • [8] PharmGKB summary: clozapine pathway, pharmacokinetics
    Thorn, Caroline F.
    Mueller, Daniel J.
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2018, 28 (09): : 214 - 222
  • [9] PharmGKB summary: voriconazole pathway, pharmacokinetics
    Barbarino, Julia M.
    Obeng, Aniwaa Owusu
    Klein, Teri E.
    Altman, Russ B.
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (05): : 201 - 209
  • [10] PharmGKB summary: oxycodone pathway, pharmacokinetics
    Huddart, Rachel
    Clarke, Melissa
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2018, 28 (10): : 230 - 237